Oral contraceptives and venous thromboembolism

BMJ (Online)

Volumn 339, Issue 7720, 2009, Pages 521-

  Dunn, Nick ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYPROTERONE ACETATE; DESOGESTREL; DROSPERINONE; ETHINYLESTRADIOL; GESTAGEN; GESTODENE; LEVONORGESTREL; NORETHISTERONE; NORGESTIMATE; ORAL CONTRACEPTIVE AGENT; UNCLASSIFIED DRUG;

ACNE VULGARIS; CLINICAL PRACTICE; DRUG INFORMATION; EDITORIAL; GENE MUTATION; HETEROZYGOTE; HUMAN; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; VENOUS THROMBOEMBOLISM;

CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HUMANS; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 69949098181     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b3164     Document Type: Editorial

References (7)

1. WHO. Cardiovascular disease and steroid hormone contraception. Technical Report Series 877. Geneva: WHO, 1998.
2. Van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, Doggen CJM, Rosendaal FR. Effects of oestrogen dose and progestogen type on venous thrombotic risk associated with oral contraceptives: results of the MEGA case-control study. BMJ 2009:339:b2921.
3. Lidegaard Ø, Løkkegaard E, Svendsen AL, Agger C. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ 2009;339:b2890.[Abstract/Free Full Text]
4. Heinemann LAJ, Dinger J. Safety of a new oral contraceptive containing drosperinone. Drug Safe 2004;27:1001-1008[CrossRef] (Pubitemid 39487064)
5. Shulman LP, Goldzieher JW. The truth about oral contraceptives and venous thromboembolism. J Reprod Med 2003;48(11 suppl):930-938[Web of Science][Medline]
6. Vandenbroucke JP, Rosing J, Bloemenkamp KWM, Helmerhorst FM, Bouma BN, et al. Oral contraceptives and the risk of venous thrombosis. N Engl J Med 2001;344:1527-1535[Free Full Text] (Pubitemid 32429213)
7. Amy J-J, Tripathi V. Contraception for women: an evidence based overview. BMJ 2009;339:b2895.[Free Full Text]